Bank of America Cuts ProKidney (NASDAQ:PROK) Price Target to $3.00

ProKidney (NASDAQ:PROK – Free Report) had its price objective reduced by Bank of America from $4.00 to $3.00 in a report released on Wednesday, Benzinga reports. They currently have a neutral rating on the stock. Separately, Jefferies Financial Group dropped their price objective on ProKidney from $15.00 to $6.00 and set a buy rating on […]

Leave a Reply

Your email address will not be published.

Previous post UBS Group Cuts Finance of America Companies (NYSE:FOA) Price Target to $14.00
Next post Fixing the Massachusetts State Police: The new colonel’s long road ahead